Preclinical investigations of concomitant tumor treating fields (TTFields) with cisplatin or paclitaxel for treatment of cervical cancer

被引：0
|
作者：
Frechtel-Gerzi, Roni
Gerasimova, Daria
Zeevi, Einav
Schlachet-Drukerman, Inbar
Mumblat, Helena
Martinez-Conde, Antonia
Dor-On, Eyal
Tzchori, Itai
Haber, Adi
Giladi, Moshe
Weinberg, Uri
Palti, Yoram
Palmer, Greg
Secord, Angeles A.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2666
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2666
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pan cancer transcriptomic response to tumor treating fields (TTFields)
    Wainer-Katsir, Kerem
    Lavy-Shahaf, Gitit
    Fishman, Hila
    Ena, Hila
    Frechtel-Gerzi, Roni
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Davidi, Shiri
    Jacobovitch, Sara
    Tzchori, Itai
    Porat, Yaara
    Ding, Lianghao
    Story, Michael
    Du, Renfei
    Kahlert, Ulf
    Mannarino, Laura
    Mirimao, Federica
    Lupi, Monica
    D'Incalci, Maurizio
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Tumor Treating Fields (TTFields): New Perspectives for Cancer Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (10) : 543 - 543
  • [23] Tumor Treating Fields (TTFields) together with PARP inhibitors for treatment of pancreatic cancer cells
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Dor-On, Eyal
    Lamichhane, Puru
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (02)
  • [24] Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
    Davidi, Shiri
    Jacobovitch, Sara
    Shteingauz, Anna
    Martinez-Conde, Antonia
    Braten, Ori
    Tempel-Brami, Catherine
    Zeevi, Einav
    Frechtel-Gerzi, Roni
    Ene, Hila
    Dor-On, Eyal
    Voloshin, Tali
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    CANCERS, 2022, 14 (12)
  • [25] THE EFFICACY OF TEMOZOLOMIDE AND LOMUSTINE IN GLIOBLASTOMA CELL LINES MAY BE ENHANCED BY CONCOMITANT TREATMENT WITH TUMOR TREATING FIELDS (TTFIELDS)
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2022, 24 : 92 - 92
  • [26] Efficacy of concomitant application of Tumor Treating Fields (TTFields), temozolomide and lomustine in glio blastoma cancer cells in vitro
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [27] THE INOVIVO SYSTEM: A NOVEL PRECLINICAL TOOL FOR IN VIVO DELIVERY OF TUMOR TREATING FIELDS (TTFIELDS)
    Davidi, Shiri
    Blat, Roni
    Shteingauz, Anna
    Porat, Yaara
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2020, 22 : 104 - 104
  • [28] The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro
    Munster, Mijal
    Schneiderman, Rosa
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Shteingauz, Anna
    Kayna, Noa
    Zeevi, Einav
    Gotlib, Karnit
    Giladi, Moshe
    Kirson, Eilon
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    CANCER RESEARCH, 2019, 79 (13)
  • [29] SENSITIVITY OF TUMOR TREATING FIELDS (TTFIELDS) TREATMENT PLANNING TO TUMOR SEGMENTATION ERRORS
    Ze'evi, Oshrit
    Marciano, Tal
    Naveh, Ariel
    NEURO-ONCOLOGY, 2022, 24 : 292 - 292
  • [30] The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed Inhibit Mesothelioma Cells In Vitro
    Munster, M.
    Schneiderman, R. S.
    Porat, Y.
    Voloshin, T.
    Davidi, S.
    Shteingauz, A.
    Kaynan, N.
    Zeevi, E.
    Gotlib, K.
    Giladi, M.
    Kirson, E.
    Weinberg, U.
    Kinzel, A.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 239 - 239
12345